Antibody (1)
Launched (1)
Mouse (1)
- (1)
Unconjugated (1)
| Cat. No. | Species | Host | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|---|
NO1-MY2188 | HEK293 | Monoclonal Anti-Human NoV VP1 Antibody, Mouse IgG1 (5B4) (MALS verified) |
| English Name | Research Code | Highest Development Stage | Company | Earliest Brand Name | Earliest Approval Country | Earliest Indication | Earliest Approval Company | Earliest Approval Date | Indication | Clinical Trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Vindesine sulfate | Compound-112531 | Approved | Eli Lilly And Company | Eldisine | United Kingdom | Lymphoma; Melanoma; Breast Neoplasms; Esophageal Neoplasms; Lung Neoplasms; Small Cell Lung Carcinoma; Carcinoma, Non-Small-Cell Lung; Leukemia | Eli Lilly And Company | 1979-01-01 | Leukemia; Esophageal Neoplasms; Small Cell Lung Carcinoma; Breast Neoplasms; Lymphoma; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Melanoma | Details |




